Topical Preparation of Pomegranate and Ginkgo Biloba for Anti-aging Activities
Launched by AHMED A. H. ABDELLATIF · Dec 8, 2018
Trial Information
Current as of August 30, 2025
Unknown status
Keywords
ClinConnect Summary
In this study, a vanishing cream will be prepared by reaction of a stearic acid with alkali (NaOH) to form stearate soap. Then the GB extract will be added to the final form. The formulated cream will be characterized for identifying the type of emulsion, calibration curve for GB, drug content, irritation to skin, homogeneity test, pH, FT-IR test, ex vivo studies, physical stability, and human application. Finally, a 9-questions questionnaire was published using Google forms for the human volunteers.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of aging shape
- • Follow up and collect data for a local and systemic activity of Ginkgo Biloba and Pomegranate
- • The skin should be not injured as the cream can be easily applied
- • Systemic oral capsule Ginkgo Biloba and Pomegranate can be also given to enhance the activity as anti-aging activity
- Exclusion Criteria:
- • Insulin-dependent diabetes
- • Hypertension disease
- • Skin wound
About Ahmed A. H. Abdellatif
Ahmed A. H. Abdellatif is a dedicated clinical trial sponsor with a focus on advancing medical research and enhancing patient care. With a strong background in clinical pharmacology and a commitment to ethical research practices, Abdellatif aims to facilitate innovative studies that explore new therapeutic options and improve treatment outcomes. By fostering collaboration among healthcare professionals, researchers, and regulatory bodies, he strives to ensure the integrity and efficacy of clinical trials while prioritizing patient safety and well-being. His work is characterized by a meticulous approach to trial design and execution, contributing to the advancement of medical knowledge and the development of novel therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Buraidah, Qassim, Saudi Arabia
Buraidah, Qassim, Saudi Arabia
Patients applied
Trial Officials
Ahmed Abdellatif, Ph.D.
Principal Investigator
Assistant Prof. at Pharmaceutics dept., Faculty of Pharmacy, Qassim University, KSA
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials